Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Cannabis Use Disorder
NCT07783555Phase 2Not yet recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2026
- Primary completion
- Nov 2031
01
Overview
A Phase 2 trial of varenicline in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
varenicline
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT07783555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07783555.